Collections

Filters ​

  • Collection |

    May is Brain Cancer Awareness Month and in this Collection we highlight a selection of recent Reviews and research Articles published in BJC focusing on research into this cancer of unmet need, covering the insights into the cellular and molecular mechanisms underlying in brain cancer, improvements in diagnostic and prognostic markers, experimental therapeutics and outcomes from clinical trials continuing to develop treatment for patients.

  • Series |

    With an ever-growing body of oncology research, BJC Reviews seek to summarise and condense that information into thought-provoking commentaries. They cover a broad remit of oncology research, from the cellular and molecular events that underpin tumorigenesis and disease progression, to existing and emerging therapeutics and clinical cancer management. Our recent review articles are presented for you in this evolving Collection; we hope you enjoy reading them.

    Image: David Becker/ The Image Bank / Getty Images Plus

  • Series |

    The Cellular and Molecular Biology subject category is edited by Professor Margaret Ashcroft (Cambridge, UK). Click the image above for the latest research from this subject category

    Image: JUAN GAERTNER/SCIENCE PHOTO LIBRARY; KATERYNA KON/SCIENCE PHOTO LIBRARY

  • Series |

    The Clinical Subject category is edited by Professor Jeffry Evans (Glasgow, UK) and Professor Stephen Chia (Vancouver, Canada). Click the image above for the latest research from this subject category

    Image: JUAN GAERTNER/SCIENCE PHOTO LIBRARY; KATERYNA KON/SCIENCE PHOTO LIBRARY

  • Collection |

    The Covid-19 pandemic has had an impact globally, particularly effecting people with underlying medical conditions and weakened immune systems. In this Collection, we bring together our articles on the impact of Covid-19 on cancer.

    Image: Gerd Altmann / Pixabay

  • Series |

    The Epidemiology subject category is edited by Professor Per Hall (Stockholm, Sweden) and Professor Rulla Tamimi (New York, USA). Click the image above for the latest research from this subject category

    Image: JUAN GAERTNER/SCIENCE PHOTO LIBRARY; KATERYNA KON/SCIENCE PHOTO LIBRARY

  • Series |

    The Genetics and Genomics Subject category is edited by Professor Angela Cox (Sheffield, UK). Click the image above for the latest research from this subject category

    Image: JUAN GAERTNER/SCIENCE PHOTO LIBRARY; KATERYNA KON/SCIENCE PHOTO LIBRARY

  • Special |

    The incurability of metastatic cancer is currently an unmet clinical need which needs to be addressed. This Collection on Metastasis highlights the ongoing challenges in the field and research being undertaken to more thoroughly understand models of metastasis, disrupt the metastatic cascade, and improve treatment outcomes for patients. Featuring Special Issue content that has been curated by Suzanne Fuqua (Baylor College of Medicine, USA), this Collection contains a selection of articles and commissioned content from leading researchers, to present a broad-scope view of current research focal points and explore future directions of cancer metastasis.

    Image: David A. Litman/Shutterstock
    Open for submissions

  • Series |

    The Molecular Diagnostics subject category is edited by Dr Lynette Sholl (Boston, USA). Click the image above for the latest research from this subject category

    Image: JUAN GAERTNER/SCIENCE PHOTO LIBRARY; KATERYNA KON/SCIENCE PHOTO LIBRARY

  • Series |

    The Translational Therapeutics subject category is edited by Dr Suzanne Fuqua (Houston, USA) and Dr Niels Halama (Heidelberg, Germany). Click the image above for the latest research from this subject category

    Image: JUAN GAERTNER/SCIENCE PHOTO LIBRARY; KATERYNA KON/SCIENCE PHOTO LIBRARY

  • Collection |

    April is Oesophageal Cancer Awareness Month and in this Collection we highlight a selection of recent Reviews and research Articles published in BJC focusing on research into oesophageal cancer, covering the epidemiology of oesophageal cancer risk, improvements in diagnostic and prognostic markers of this cancer, experimental therapeutics and outcomes from clinical trials.